Advertisement
Research Article| Volume 21, ISSUE 3, P435-474, September 2001

Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents

DOI:https://doi.org/10.1016/S0272-2712(18)30018-0
Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents
Previous ArticleHistory of the Development and Use of Biological Weapons
Next ArticleClinicopathologic Features of Viral Agents of Potential Use by Bioterrorists
      This paper is only available as a PDF. To read, Please Download here.
      Concern regarding the use of biological agents as tools of warfare or terrorism has led to measures to deter their use or to deal with the consequences. Unlike chemical agents, diseases resulting from biological agents have incubation periods of days. Rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. This article provides an updated primer on 11 classic biological warfare and potential terrorist agents to increase the likelihood of their being considered in a differential diagnosis. If the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abramova F.
        • Grinberg L.M.
        • Yampolskaya O.V.
        • et al.
        Pathology of inhalational anthrax in 42 cases from the Sverdlosk outbreak of 1979.
        Proc Nat Acad Sci. 1993; 90: 2291
        • Acklund J.
        • Worswick D.A.
        • Marmion B.P.
        Vaccine prophylaxis of Q fever.
        Med J Aust. 1994; 160: 704
        • Albretsen J.
        • Gwaltney-Brant S.M.
        • Khan S.A.
        Evaluation of castor bean toxicosis in dogs: 98 cases.
        Journal of the American Animal Hospital Association. 2000; 36: 229
        • Alibek K.
        Biohazard. Random House, New York1999

      5. Alibek K: Terrorist and Intelligence Operations: Potential Impact on the U.S. Economy. Washington, United States Congress Joint Economic Committee

        • Araj G.
        Human brucellosis: A classical infectious disease with persistent diagnostic challenges.
        Clin Lab Sci. 1999; 12: 207
        • Arita I.
        Virological evidence for the success of the smallpox eradication programme.
        Nature. 1979; 279: 293
        • Ariza J.
        • Gudiol F.
        • Valverde J.
        Brucellar spondylitis.
        Rev Infect Dis. 1983; 7: 656

      9. Association for Professionals in Infection Control and Epidemiology (APIC) Bioterrorism Task Fore, CDC Hospital Infections Program Bioterrorism Working Group. Bioterrorism Readiness Plan: A Template for Healthcare Facilities. APICT999. Available at www.apic.org/html/educ/readinow.html

        • Ayres J.
        • Flint N.
        • Smith E.G.
        • et al.
        Post-infection fatigue syndrome following Q fever.
        Q J Med. 1998; 91: 105
        • Bauer D.
        • St. Vincent L.
        • Kempe C.H.
        • et al.
        Prophylactic treatment of smallpox contacts with N-methylisatin-thiosemicarbasone (compound 33T57, Marboran).
        Lancet. 1963; 2: 494
        • Bell J.
        • Lackman D.B.
        • Meis A.
        • et al.
        Recurrent reaction at site of Q fever vaccination in a sensitized person.
        Mil Med. 1964; 129: 591
        • Benensen A.
        Control of Communicable Diseases in Man. American Public Health Association, Washington, DC1990
        • Benenson A.
        Q Fever vaccine.
        in: Smadel J. Symposium on Q Fever by the Committee on Rickettsial Diseases. Armed Forces Epidemiology Board, Washington1959: 47
        • Brachman P.
        Inhalation anthrax.
        Ann N Y Acad Sci. 1980; 167: 83
        • Brachman P.
        • Friedlander A.M.
        Anthrax.
        in: Plotkin S. Mortimer E. Vaccines. WB Saunders, Philadelphia1994: 729
        • Bray M.
        • Martiniz M.
        • Smee D.F.
        • et al.
        Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
        J Infect Dis. 2000; 181: 10
        • Briceno Rossi A.
        The frequency of VEE virus in the pharyngeal material of clinical cases of encephalitis.
        Gacetta Medicina Caracas. 1964; 72: 5
        • Briceno Rossi A.
        Rural epidemic encephalitis in Venezuela caused by a group A arbovirus (VEE).
        in: Melnick J. Progress in Medical Virology, vol 9. S. Karger AG, Basel, Switzerland1967: 175
        • Brouqui P.
        • Dupont H.T.
        • Drancourt M.
        • et al.
        Chronic Q fever.
        Arch Intern Med. 1993; 143: 643
        • Burke D.
        Immunization against tularemia.
        J Infect Dis. 1977; 135: 55
        • Butler J.
        • Peters C.J.
        Hantaviruses and hantivirus pulmonary syndrome.
        Clin J Infect Dis. 1994; 19: 387
        • Butler T.
        Yersinia species, including plague.
        in: Mandeli F. Bennett J. Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia2000: 2406
        • Byrne M.
        • Smith L.A.
        Development of vaccines for prevention of botulism.
        Biochemie. 2000; 82: 1
        • Byrne W.
        • Welkos S.L.
        • Pitt M.L.
        • et al.
        Antibiotic treatment of experimental pneumonic plague in mice.
        Antimicrob Agents Chemother. 1998; 42: 675
        • Calisher C.
        • El-Kaffawi A.O.
        • Al-Deen M.I.
        Complex specific immunoglobulin M antibody patterns in humans infected with Alphaviruses.
        J Clin Microbiol. 1986; 23: 155
        • Calisher C.
        • Karabatsos N.
        Arbovirus serogroups: Definition and geographic distribution.
        in: Monath I.T. The Arboviruses: Epidemiology and Ecology. CRC Press, Boca Raton1998: 19
        • Cameron G.
        • Pate J.
        • McCauley D.
        • et al.
        WMD Terrorism Chronology: Incidents Involving Sub-national Actors and Chemical, Biological, Radiological and Nuclear Materials. Monterey Institute of International Studies, Monterey, CA1999
        • Canonico P.
        • Kende M.
        • Luscri B.J.
        • et al.
        In-vivo activity of antivirals against exotic RNA viral infections.
        J Antimicrob Chemother. 1984; 14: 27
        • Cavanaugh D.
        • Cadigan F.C.
        • Williams J.E.
        • et al.
        General medicine and infectious diseases.
        in: Ognibene A. Barrett O. Internal Medicine in Viet Nam. Office of the Surgeon General and Center of Military History, Washington1982
        • Cavanaugh D.
        • Ellsberg B.L.
        • Llewellyn C.H.
        • et al.
        Plague immunization.
        J Infect Dis. 1974; 129: S37
        • Centers for Disease Control and Prevention
        Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998.
        MMWR Morb Mortal Wkly Rep. 1999; 48: 69

      33. Centers for Disease Control and Prevention: Ebola in Sudan. Morb Mortal Wkly Rep, in press

        • Centers for Disease Control and Prevention
        Fatal illness associated with a New-World Arenavirus - California, 1999-2000.
        MMWR Morb Mortal Wkly Rep. 2000; 49: 709
        • Centers for Disease Control and Prevention
        Human monkeypox - Kasai oriental, Zaire.
        MMWR Morb Mortal Wkly Rep. 1997; 46: 304
        • Centers for Disease Control and Prevention
        Management of patients with suspected viral hemorrhagic fever.
        MMWR Morb Mortal Wkly Rep. 1988; 37: 1
        • Chan R.
        • Hardiman R.P.
        Endocarditis caused by Brucella melitensis.
        Med J Aust. 1993; 158: 631
        • Clark D.
        Two non-fatal human infections with the virus of eastern encephalitis.
        Am J Trop Med Hyg. 1961; 10: 67
        • Cochrane R.
        Biological warfare research in the United States. In History of the Chemical Warfare Service in World War II, vol 2. US Department of the Army, Frederick, MD1947
        • Coimbra T.
        • Nassar E.S.
        • Burattini M.N.
        • et al.
        New Arenavirus isolated in Brazil.
        Lancet. 1994; 343: 391
        • Cole L.
        Bioterrorism threats: Learning from inappropriate responses.
        Journal of Public Health Management Practice. 2000; 6: 8
        • Colmenero C.
        • Hernandez A.E.
        • Espinosa A.
        Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.
        Chemotherapy. 1989; 35: 146
        • Colmenero J.
        • Reguera J.M.
        • Sanchez M.F.
        • et al.
        Complications associated with brucella melitensis infection: A study of 530 cases.
        Medicine. 1996; 75: 195
        • Conley J.
        • Yang H.
        • Wilson T.
        • et al.
        Aerosol delivery of limpsome-encapsulated ciprofloxacin: Aerosol characterization and efficacy against Francisella tularensis infection in mice.
        Antimicrob Agents Chemother. 1997; 41: 1288
        • Cookson J.
        • Nottingham J.
        Survey of Chemical and Biological Warfare. Monthly Review Press, New York1969
        • Crompton R.
        • Gall D.
        • Markov G.
        Death in a pellet.
        Med Leg J. 1980; 48: 51
        • Crosby E.
        • Llosa L.
        • Miro Q.M.
        • et al.
        Hematologic changes in brucellosis.
        J Infect Dis. 1984; 150: 419

      48. CSL and Limited, Package Insert, 1992, Australia

        • Davis N.
        • Powell N.
        • Greenwald G.F.
        • et al.
        Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus.
        Virology. 1991; 183: 20
        • Department of the Army
        US Army Activity on the US Biological Warfare Programs. US Department of the Army, Washington1977
        • Deresiewicz R.
        • Thaler S.J.
        • Hsu L.L.
        • et al.
        Clinical and neuroradiographic manifestations of eastern equine encephalitis.
        N Engl J Med. 1997; 336: 1867
        • Derrick E.
        The course of infection with Coxiella burnetii.
        Med J Aust. 1973; 1: 1051
        • Dixon C.
        Smallpox. J&A Churchill, London1962
        • Downie A.
        • Meiklejohn M.
        • St. Vincent L.
        • et al.
        The recovery of smallpox from patients and their environment in a smallpox hospital.
        Bull World Health Organ. 1965; 33: 615
        • Downie A.
        • St. Vincent L.
        • Meikejohn G.
        • et al.
        Studies on the virus content of mouth washings in the acute phase of smallpox.
        Bull World Health Organ. 1961; 25: 49
        • Dupuis G.
        • Petite J.
        • Oliver P.
        • et al.
        An important outbreak of human Q fever in a Swiss alpine valley.
        Int J Epidemiol. 1987; 16: 282
        • Dutz W.
        • Kohout E.
        Anthrax.
        Pathology Annual. 1971; 6: 209
        • Easterday B.
        Rift Valley Fever.
        Advances in Veterinary Science. 1965; 10: 65
        • Enria D.
        • Fernandez N.
        • Briggiler A.J.
        • et al.
        Importance of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma.
        Lancet. 1984; 4: 225
        • Enria D.
        • Maiztegui J.I.
        Antiviral treatment of Argentine hemorrhagic fever.
        Antiviral Res. 1994; 23: 23
        • Evans A.
        Comments on the early history of human brucellosis.
        in: Larson C. Soule M. Brucellosis. Waverly Press, Baltimore1950: 1
        • Evans M.
        • Friedlander A.M.
        Tularemia.
        in: Zajtchuk R. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. The Borden Institute, US Army, Washington, DC1997: 503
        • Evans M.
        • Gregory D.W.
        • Schafner W.
        • et al.
        Tularemia.
        Medicine. 1985; 64: 251
        • Ezzell J.
        • Abshire T.G.
        • Little S.F.
        • et al.
        Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosame polysaccharide.
        J Clin Microbiol. 1990; 28: 223
        • Federal Emergency Management Agency
        The Federal Response Plan for Public Law 93-288, As Amended. DC, Washington1992
        • Feemster R.
        Equine encephalitis in Massachusetts.
        N Engl J Med. 1957; 257: 701

      67. Fenner F, Henderson DA, Arita I et al: Smallpox and Its Eradication. Geneva, World Health Organization, 1988, p 1341

        • Ferrante M.
        • Dolan M.J.
        Q Fever meningoencephalitis in a soldier returning from the Persian Gulf War.
        Clin Infect Dis. 1993; 16: 489
        • Fiori P.
        • Mastrandea S.
        • Rappelli P.
        • et al.
        Brucella abortus infection acquired in microbiology laboratories.
        J Clin Microbiol. 2000; 38: 2005
        • Formenty P.
        • Hatz C.
        • LeGuenno B.
        • et al.
        Human infection due to Ebola virus, subtype Cote dTvoire: Clinical and biologic presentation.
        J Infect Dis. 1999; 179: S48
        • Fostad O.
        • Kvalheim G.
        • Godal A.
        • et al.
        Phase I study of the plant protein ricin.
        Cancer Res. 1984; 44: 862
        • Franck P.
        • Johnson K.M.
        An outbreak of Venezuelan equine encephalitis in man in the Panama Canal Zone.
        Am J Trop Med Hyg. 1970; 19: 860
        • Franz D.
        • Jaax N.K.
        Ricin toxin.
        in: Zajtchuk R. Medical Aspects of Chemical and Biological Warfare. The Borden Institute, Washington, DC1997: 631
        • Franz D.
        • Jahrling P.B.
        • Friedlander A.M.
        Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents.
        JAMA. 1997; 278: 399
        • Franz D.
        • Parrott C.D.
        • Takafuji E.T.
        The US biological warfare and biological defense programs.
        in: Zajtchuk R. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. The Borden Institute, Washington, DC1997: 425
        • Franz D.
        • Pitt L.M.
        • Clayton M.A.
        • et al.
        Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism.
        in: Das Gupta B. Botulinum and Tetanus Neurotoxins and Biomedical Aspects. Plenum Press, New York1993: 473
        • Fraser J.
        High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.
        Nature. 1989; 339: 221
        • Friedlander A.
        Anthrax.
        in: Zajtchuk R. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Borden Institute, Washington, DC1997: 467
        • Friedlander A.
        • Welkos S.L.
        • Pitt L.M.
        • et al.
        Postexposure prophylaxis against experimental inhalation anthrax.
        J Infect Dis. 1993; 167: 1239
        • Geisbert T.
        • Hensley L.E.
        • Gibb T.R.
        • et al.
        Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.
        Lab Invest. 2000; 80: 171
        • Georges A.
        • Leroy E.M.
        • Renaut A.A.
        • et al.
        Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997.
        J Infect Dis. 1999; 179: S65

      82. Gill D: Bacterial toxins: A table of lethal amounts. Microbiol Rev, p 86, 1982

        • Gold H.
        • Hampil B.
        Equine encephalomyelitis in a laboratory technician with recovery.
        Ann Intern Med. 1942; 16: 556
        • Goldfield M.
        • Welsh J.N.
        • Taylor B.F.
        The 1959 outbreak of eastern encephalitis in New Jersey.
        Am J Epidemiol. 1968; 87: 32

      85. Goodman P: Seized poison set off few alarms. Anchorage Daily News, January 4, 1996, p B-l

        • Gotuzzo E.
        • Alarcon G.S.
        • Bocanegra T.S.
        • et al.
        Articular involvement in human brucellosis.
        Semin Arthritis Rheum. 1982; 12: 245
        • Gotuzzo E.
        • Carillo C.
        • Guerro J.
        • et al.
        An evaluation of diagnostic methods for brucellosis.
        J Infect Dis. 1986; 153: 122
        • Grimont F.
        • Verger J.M.
        • Cornells P.
        • et al.
        Molecular typing of brucella with cloned DNA probes.
        Res Microbiol. 1992; 143: 55
        • Gu M.-L.
        • Leppla S.H.
        • Klinman D.M.
        Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen.
        Vaccine. 1999; 17: 340
        • Harper G.
        Airborne microorganisms.
        J Hyg. 1961; 59: 479
        • Harris S.
        Factories of Death. Routledge, London1994
        • Hart K.
        • Keen D.
        • Belle E.A.
        An Outbreak of eastern equine encephalomyelitis in Jamaica, West Indies, Nov-Dec 1962. I: Description of human cases.
        Am J Trop Med Hyg. 1964; 13: 331
        • Hart M.
        • Caswell-Stephan K.
        • Bakken R.
        • et al.
        Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
        Vaccine. 2000; 18: 3067
        • Hayes R.
        Eastern and Western encephalitis.
        in: Beran G. Handbook Series in Zoonoses: Viral Zoonoses. CRC Press, Boca Raton, FL1981: 29
        • Heath D.
        • Anderson G.W.
        • Mauro J.M.
        • et al.
        Protection against experimental bubonic and pneumonic plague with a recombinant capsular Fl-V antigen fusion protein vaccine.
        Vaccine. 1998; 16: 1131
        • Henderson D.
        Smallpox.
        in: Maxcy-Rosenau Sartwell P. Preventive Medicine and Public Health by Maxcy-Rosenau. ed 10. Appleton Century Crofts, New York1973: 104
        • Hevey M.
        • Negley D.
        • Pushko P.
        • et al.
        Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
        Virology. 1998; 251: 28
        • Hinman A.
        • McGowan J.E.
        • Henderson B.E.
        Venezuelan equine encephalomyelitis.
        Am J Epidemiol. 1971; 93: 130
        • Horgan E.
        • Haseeb M.A.
        Cross immunity experiments in monkey between variola, alastrim and vaccinia.
        J Hyg. 1939; 39: 615
        • Huggins J.
        Prospects for treatment of viral hemorrhagic fevers with Ribavirin, a broad-spectrum antiviral drug.
        Rev Infect Dis. 1989; 11: S750
        • Hunt A.
        • Roerhrig J.T.
        Biochemical and biological characteristics of epitopes on the El glycoprotein of western equine encephalitis virus.
        Virology. 1982; 142: 334
        • Huxsoll D.
        • Patrick W.C.
        • Parrott C.D.
        Veterinary services in biological disasters.
        J Am Vet Med Assoc. 1987; 190: 714
        • Ibrahim A.
        • Shetty S.D.
        • Saad M.
        • et al.
        Genito-urinary complications of brucellosis.
        Br J Urol. 1983; 61: 294
        • Ibrahim S.
        • Esposito J.J.
        • Jahrling P.B.
        • et al.
        The Potential of 5 nuclease PCR for detecting a single-base polymorphism in orthopoxviruses.
        Mol Cell Probes. 1997; 11: 143
        • Inglesby T.
        • Dennis D.T.
        • Henderson D.A.
        • et al.
        Plague as a biological weapon.
        JAMA. 2000; 283: 2281
        • Iyorlumun I.
        • Uhaa D.B.
        • Fishbein J.G.
        • et al.
        Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever.
        J Clin Microbiol. 1994; 32: 1560
        • Jahans K.
        • Foster G.
        • Broughton E.S.
        The characterization of brucella strains isolated from marine mammals.
        Vet Microbiol. 1997; 57: 373
        • Jahrling P.
        Filoviruses and arenaviruses.
        in: Murray P. Baron P.R. Pfaller M.A. Manual of Clinical Microbiology. ASM Press, Washington, DC1995: 1068
        • Jahrling P.
        • Geisbert J.
        • Swearingen J.
        • et al.
        Endemic Lassa fever in Liberia.
        Trans R Soc Trop Med Hyg. 1985; 79: 380
        • Jahrling P.
        • Geisbert J.
        • Swearingen J.
        • et al.
        Passive immunization of Ebola virus-infected Cynomulgus Monkeys with immunoglobulin from hyperimmune horses.
        Arch Virol. 1996; 11: 135
        • Jezek Z.
        • Fenner F.
        Human monkeypox.
        Virology Monographs. 1988; 17: 93
        • Johnson K.
        • Martin D.H.
        Venezuelan equine encephalitis.
        Adv Vet Sci. 1974; 18: 79
        • Johnson K.
        • Wiebenga N.H.
        • Mackenzie B.
        • et al.
        Virus isolations from human cases of hemorrhagic fever in Bolivia.
        Proc Soc Exp Biol Med. 1965; 155: 113
      114. Joint FAO/WHO Export Committee on Brucellosis.
        World Health Organ Tech Rep Ser. 1986; 740: 1
        • Kappler J.
        • Kotzin B.
        • Herron L.
        • et al.
        VB(Beta)-specific stimulation of human T cells by staphylococcal toxins.
        Science. 1989; 20: 163

      116. Karabatsos N: International catalogue of arboviruses including certain other viruses of vertebrates. Am Soc Trop Med Hyg 1985

        • Kato S.
        • Takahashi M.
        • Kameyama
        • et al.
        A Study on the morphological and cyto-immunological relationship between the inclusions of variola, cowpox, rabbitpox, vaccinia (variola origin) and vaccinia IHD and consideration of the term “Guarneri body”.
        Biken Journal. 1959; 2: 353

      118. Kifner J: Man is arrested in a ‘case involving deadly poison. New York Times. December 23, 1995, p A-7

        • Kijek T.
        • Rossi C.A.
        • Moss D.
        • et al.
        Rapid and sensitive immunomagnetic-electrochemi-luminescent detection of staphyloccocal enterotoxin B.
        J Immunol Methods. 2000; 236: 9
        • Kilgore P.
        • Ksiazek T.G.
        • Rollin P.E.
        • et al.
        Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.
        Clin Infect Dis. 1997; 24: 718
        • Krakauer T.
        Immune response to staphylococcal superantigens.
        Immunol Res. 1999; 20: 163
        • Lackman D.
        • Bell E.J.
        • Bell J.F.
        • et al.
        Intradermal sensitivity testing in man with a purified vaccine for Q fever.
        Am J Public Health. 1962; 52: 87

      123. Langmuir A, Andrews JM: Biological warfare defense 2. The Epidemic Intelligence Service of the Communicable Disease Center. Am J Public Health 42: 1952

      124. LeDuc J, Jahrling PB: Developing national preparedness for smallpox: An update. Emerg Infect Dis 7, 2001

        • Lee H.
        Hemorrhagic fever with renal syndrome in Korea.
        Rev Infect Dis. 1989; 11: S8649
        • Leon C.
        • Jaramillo R.
        • Martinez S.
        • et al.
        Sequelae of Venezuelan equine encephalitis in humans: A four-year follow-up.
        Int J Epidemiol. 1975; 4: 131
        • Mac Callum F.
        • McDonald J.R.
        Survival of variola virus in raw cotton.
        Bull World Health Organ. 1957; 16: 247
        • Maiztegui J.
        • Feuillade M.
        • Briggilera A.
        Progressive extension of the endemic area and changing incidence of Argentine hemorrhagic fever.
        Med Microbiol Immunol. 1986; 175: 149
        • Marrie T.
        Coxiella burnetii (Q fever) pneumonia.
        Clin Infect Dis. 1995; 21: S253
        • Marrie T.
        • Langille D.
        • Papukna V.
        • et al.
        Truckin’ pneumonia: An outbreak of Q fever in a truck repair plant.
        Epidemiol Infect. 1989; 102: 119
        • Martalon B.
        • Ormsbee R.A.
        • Kyrkor M.
        Vaccine prophylaxis of abbattoir-associated Q fever.
        Epidemiol Infect. 1990; 104: 275
        • Martin D.
        • Eddy G.A.
        • Sudia D.W.
        • et al.
        An epidemiological study of Venezuelan equine encephalomyelitis in Costa Rica.
        Am J Epidemiol. 1972; 95: 565
        • Martini C.
        • Siegert R.
        Marburg Virus Disease. Springer-Verlag, New York1971
        • Mathews J.
        • Roerhrig J.T.
        Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.
        J Immunol. 1982; 129: 2763
        • McCormick J.
        • King L.J.
        • Webb P.A.
        • et al.
        Lassa fever: Effective therapy with ribavirin.
        N Engl J Med. 1986; 314: 20
        • McCormick J.
        • Webb P.A.
        • Krebs J.W.
        • et al.
        A prospective study of epidemiology and ecology of Lassa fever.
        J Infect Dis. 1987; 155: 437
        • McCrumb F.
        Aerosol infection of man with Pasteurella tularesis.
        Bacteriology Review. 1961; 25: 262
        • McCrumb F.
        • Mercier S.
        • Robic J.
        • et al.
        Chloramphenicol and terramycin in the treatment of pneumonic plague.
        Am J Med. 1953; 41: 284
        • McKinney R.
        • Berge T.O.
        • Sawyer W.D.
        • et al.
        Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man.
        Am J Trop Med Hyg. 1963; 12: 597
        • Meiklejohn G.
        • Kempe C.H.
        • Downie A.W.
        • et al.
        Air sampling to recover variola virus in the environment of a smallpox hospital.
        Bull World Health Organ. 1961; 25: 63
        • Meselson M.
        • Guillemin J.
        • Hugh-Jones M.
        • et al.
        The Sverdlosk anthrax outbreak of 1979.
        Science. 1994; 266: 1202
        • Middlebrook J.
        Contributions of the U.S. Army to botulinum toxin research.
        in: Das Gupta B. Botulinum and Tetanus Neurotoxins and Biomedical Aspects. Plenum Press, New York1993: 515
        • Miller R.
        • Bates J.H.
        Pleuropulmonary tularemia.
        Am Rev Respir Dis. 1969; 99: 31
        • Mitra A.
        • Sarkar J.K.
        • Mukherjee M.K.
        Virus content of smallpox scabs.
        Bull World Health Organ. 1974; 51: 106
        • Mollick J.
        • Cook R.G.
        • Rich R.R.
        Class II MHC molecules are specified receptors for staphylococcal enterotoxin A.
        Science. 1989; 244: 811
        • Monath T.
        Yellow fever: Epidemics and search in the last forty years and prospects for the future.
        Am J Trop Med Hyg. 1991; 45: 1
        • Morata P.
        • Queipo-Ortuno M.I.
        • Reguera J.M.
        • et al.
        Posttreatment follow-up of brucellosis by PCR assay.
        J Clin Microbiol. 1999; 37: 4163
        • Morrill J.
        • Mebus C.A.
        • Peters C.J.
        Safety and efficacy of a mutagen-attenuated Rift Valley fever vaccine in cattle.
        Am J Vet Res. 1997; 58: 2204
        • Mousa A.
        • Elhag K.M.
        • Khogali M.
        • et al.
        Brucellosis in Kuwait.
        Trans R Soc Trop Med Hyg. 1987; 81: 1019
        • Mousa A.
        • Elhag K.M.
        • Khogali M.
        • et al.
        The nature of human brucellosis in Kuwait: Study of 379 cases.
        Rev Infect Dis. 1988; 10: 211
        • Mousa A.
        • Muhtaseb S.A.
        • Almudallal D.S.
        • et al.
        Osteoarticular complications of brucellosis.
        Rev Infect Dis. 1987; 9: 531
        • Moyer N.
        • Holcomb L.A.
        Brucella.
        in: Murray P. Manual of Clinical Microbiology. American Society for Microbiology Press, Washington, DC1995: 549

      153. Nelan B: The price of fanaticism. Time 1995, p 38

        • Olle G.
        • Canela S.J.
        An Outbreak of Brucella melitensis infection by airborne transmission among laboratory workers.
        Am J Public Health. 1987; 77: 335
        • O’Toole T.
        Smallpox: An attack scenario.
        Emerg Infect Dis. 1999; 5: 540
        • Pavlin J.
        • Eitzen Jr, E.M.
        • Caudle III, L.C.
        Biological warfare defense.
        in: Kelley P. Textbook of Military Medicine: Military Preventive Medicine: Mobilization and Deployment. Borden Institute, Washington, DC1997
        • Peery T.
        • Belter L.F.
        Brucellos and heart disease.
        Am J Pathol. 1960; 36: 673
        • Penn R.
        Francisella tularensis (tularemia).
        in: Mandeli G. Bennett J. Dolan R. Principles and Practices of Infectious Diseases. Churchill Livingstone, New York1995: 2060
        • Peters C.
        • Johnson E.D.
        • McKee K.T.
        Filoviruses and management of viral hemorrhagic fever.
        in: Belshe R. Textbook of Human Virology. Mosby-Year Book, St. Louis1991: 699
        • Pittman P.
        • Liu C.T.
        • Cannon T.L.
        • et al.
        Immunogenicity of an inactivated Rift Valley fever vaccine in humans: A 12-year experience.
        Vaccine. 1999; 18: 181
        • Pomerantsev A.
        • Staritsin N.A.
        • Mockov Y.V.
        • et al.
        Expression of cereolysine AB genes in Bacillus anthracis vaccine strain insures protection against experimental hemolytic anthrax infection.
        Vaccine. 1997; 15: 1846
        • Pushko P.
        • Bray M.
        • Ludwig G.V.
        • et al.
        Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
        Vaccine. 2000; 19: 142
        • Queipo-Ortuno M.
        • Morata P.
        • Ocon P.
        • et al.
        Rapid diagnosis of human brucellosis by peripheral-blood PCR assay.
        J Clin Microbiol. 1997; 35: 2927
        • Ramsden C.
        • Drayson M.
        • Bell F.
        The toxicity, distribution, and excretion of ricin holotoxin in rats.
        Toxicology. 1998; 55: 161
        • Rao A.
        • McKendrick G.D.W.
        • Valyudhan L.
        Assessment of an isothiazole thiosemicarbazone in the prophylaxis of contacts of variola major.
        Lancet. 1966; 1: 1072
        • Raoult D.
        Treatment of Q fever.
        Antimicrob Agents Chemother. 1993; 37: 1733
        • Raoult D.
        • Marrie T.J.
        State-of-the-art clinical lecture: Q fever.
        Clin Infec Dis. 1995; 20: 489
        • Rauber A.
        • Heard J.
        Castor bean toxicity re-examined: A new perspective.
        Vet Hum Toxicol. 1985; 27: 498

      169. Report of the Investigation Into the Cause of the 1978 Birmingham Smallpox Occurrence. London, Her Majesty’s Stationery Office, 1980

        • Richmond J.
        • McKinney R.W.
        Biosafety in Microbiological and Biomedical Laboratories. US Department of Health and Human Services, Washington, DC1993
        • Russell P.
        • Eley S.M.
        • Fulop M.J.
        • et al.
        The efficacy of ciprofloxacin and doxycydine against experimental tularemia.
        J Antimicrob Agents Chemother. 1998; 41: 461
        • Salas R.
        • De Manzione N.
        • Tesh R.B.
        • et al.
        Venezuelan hemorrhagic fever.
        Lancet. 1991; 338: 1033
        • Salmon M.
        • Howels B.
        • Giencross E.J.G.
        • et al.
        Q fever in an urban area.
        Lancet. 1982; 1: 1002

      174. Sanchez R: California anthrax threats spawn costly wave of fear. The Washington Post. 1999, A01

        • Sarkar J.
        • Mitra A.C.
        • Mukherjee M.K.
        • et al.
        Virus excretion in smallpox.
        Bull World Health Organ. 1973; 48: 517
        • Sawyer W.
        • Dangerfield H.G.
        • Hogge A.
        • et al.
        Antibiotic prophylaxis and therapy of airborne tularemia.
        Bacteriology Review. 1966; 30: 542
        • Scheel O.
        • Reiersen R.
        • Hoel T.
        Treatment of tularemia with ciprofloxacin.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 447

      178. Sharn I: Probe aims at sale of deadly bacteria. USA Today. 1995, p 2-A

        • Sheperd A.
        • Swanepoel R.
        • Leman P.A.
        Antibody response in Crimean Congo hemorrhagic fever.
        Rev Infect Dis. 1989; 11: S801
        • Simpson L.
        Peripheral actions of the botulinum toxins.
        in: Simpson L. Botulinum Neurotoxins and Tetanus Toxin. Academic Press, New York1989: 153
        • Smith D.
        • Ayres J.G.
        • Blair I.
        • et al.
        A large Q fever outbreak in the West Midlands: Clinical aspects.
        Respir Med. 1993; 87: 509
        • Smith D.
        • Welling R.
        • Walker C.
        • et al.
        The chest X-ray in Q fever: A report of 69 cases from the 1989 West Midlands outbreak.
        Br J Radiol. 1991; 64: 1101
        • Solera J.
        • Martinez A.E.
        • Espinosa A.
        Recognition and optimum treatment of brucellosis.
        Drugs. 1997; 53: 245
        • Spicer A.
        Military significance of Q fever: A review.
        J R Soc Med. 1978; 71: 762
        • Stiles B.
        • Bavari S.
        • Krakauer T.
        • et al.
        Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide.
        Infect Immun. 1993; 61: 5333
        • Szilagyi M.
        • Rivera V.R.
        • Neal D.
        • et al.
        Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
        Toxicon. 2000; 38: 381
        • Tieh T.
        • Landover E.
        • Miyagawa F.
        • et al.
        Primary pneumonic plague in Mukden, 1946, and report of 39 cases with 3 recoveries.
        J Infect Dis. 1948; 82: 52
        • Tigertt W.
        • Benenson A.S.
        Studies of Q fever in man.
        Transactions of the Association of American Physicians. 1956; 69: 98
        • Tucker J.
        Historical trends related to bioterrorism: An empirical analysis.
        Emerg Infect Dis. 1999; 5: 498
        • Turnbull P.
        Proceedings of the International Workshop on Anthrax.
        Salisbury Medical Bulletin. 1996; 87: 1
        • Ulrich R.
        • Olson M.A.
        • Bavari S.
        Development of engineered vaccines effective against structurally related bacterial superantigens.
        Vaccine. 1998; 16: 1857
        • Ulrich R.
        • Sidells S.
        • Taylor T.T.
        • et al.
        Staphylococcal enterotoxin B and related pyrogenic toxins.
        in: Zajtchuk R. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. US Dept, of the Army, The Surgeon General and the Borden Institute, Washington, DC1997: 621
        • van Eden P.
        • van Eden S.F.
        • Joubert J.R.
        • et al.
        A nosocomial outbreak of Crimean Congo hemorrhagic fever at Tygerberg Hospital.
        S Afr Med J. 1985; 68: 718
        • Waag D.
        • Chulay J.
        • Marrie T.
        • et al.
        Validation of an enzyme immunoassay for serodiagnosis of acute Q fever.
        Eur J Clin Microbiol Infect Dis. 1995; 14: 421

      195. Wald M: Suspicious package prompts 8-hour vigil at B’nai B’rith. New York Times, April 25, 1997, p A12

        • Wehrle P.
        • Posch J.
        • Richter K.H.
        • et al.
        An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe.
        Bull World Health Organ. 1970; 43: 669
        • Wilhelmsen C.
        • Pitt I.
        Lesions of acute inhaled lethal ricin intoxication in Rhesus monkeys.
        Vet Pathol. 1993; 30: 482
        • Williams P.
        • Wallace D.
        Unit 731. The Free Press, New York1989
        • Wilson J.
        • Hevey M.
        • Baaken R.
        • et al.
        Epitopes involved in anti-body-mediated protection from Ebola virus.
        Science. 2000; 287: 1664

      200. World Health Organization: Health Aspects of Chemical and Biological Weapons: Report of a WHO Group of Consultants. Geneva, WHO, 1970, p 69

        • World Health Organization International Study Team
        Ebola hemorrhagic fever in Sudan, 1976.
        Bull World Health Organ. 1978; 56: 247
        • World Health Organization International Study Team
        Ebola hemorrhagic fever in Zaire, 1976.
        Bull World Health Organ. 1978; 56: 271
        • Yagupsky P.
        • Peled N.
        • Press J.
        • et al.
        Rapid detection of Brucella melitensis from blood cultures by a commercial system.
        Eur J Clin Microbiol Infect Dis. 1997; 16: 605
        • Young E.
        Serologic diagnosis of human brucellosis: Analysis of 214 cases by agglutination tests and review of the literature.
        Rev Infect Dis. 1991; 13: 359
        • Young E.J.
        An overview of human brucellosis.
        Clin Infect Dis. 1995; 21: 283
        • Zdenek J.
        Human Monkeypox. Switzerland, S. Karger, Basel1988

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30018-0

      Copyright

      © 2001 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX